Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial
Titel:
Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double-blind, placebo-controlled trial
Auteur:
Leaker, Brian R. O'Connor, B. Hansel, Trevor T. Barnes, Peter J. Meng, Lixen Mathur, Vandana S. Lieu, Hsiao D.